Literature DB >> 2299182

Diagnosis and treatment of 106 cases of human brucellosis.

A Shehabi1, K Shakir, M el-Khateeb, H Qubain, N Fararjeh, A R Shamat.   

Abstract

During the year 1987, 106 cases of human brucellosis were studied prospectively at the Jordan University Hospital. The disease was more often diagnosed among adults (73.6%) than children (26.4%). Serious clinical complications were observed in 5.7% patients. An initial Brucella antibody titre greater than or equal to 160 proved to be reliable in confirming suspected cases of acute and subacute brucellosis. Culture of blood was found to be more sensitive (44.4%) and significant (P less than 0.02) than bone marrow culture (27.7%) for detecting Brucella melitensis. All patients treated with rifampicin plus tetracycline or co-trimoxazole were considered to be clinically cured by disappearance of all major clinical features of brucellosis. By contrast, 2/10 patients treated with rifampicin alone, as well as 1/56 patients treated with tetracycline and streptomycin, clinically relapsed. It is evident from this study that the treatment with rifampicin alone is not as effective in brucellosis as it is when given with another appropriate drug.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2299182     DOI: 10.1016/s0163-4453(90)92214-6

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  16 in total

Review 1.  Detection of Brucellae in blood cultures.

Authors:  P Yagupsky
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

2.  Acute epididymo-orchitis from brucellosis melitensis in Australia.

Authors:  Christopher Chi Kit Ip; Khrisna Tumali; Ivan M Hoh; Arun Arunasalam
Journal:  BMJ Case Rep       Date:  2019-07-10

Review 3.  Laboratory Diagnosis of Human Brucellosis.

Authors:  Pablo Yagupsky; Pilar Morata; Juan D Colmenero
Journal:  Clin Microbiol Rev       Date:  2019-11-13       Impact factor: 26.132

4.  Epidemiological aspects of brucellosis in Jordan.

Authors:  Q M Abu Shaqra
Journal:  Eur J Epidemiol       Date:  2000-06       Impact factor: 8.082

5.  Human brucellosis in Macedonia - 10 years of clinical experience in endemic region.

Authors:  Mile Bosilkovski; Ljiljana Krteva; Marija Dimzova; Ivan Vidinic; Zaklina Sopova; Katerina Spasovska
Journal:  Croat Med J       Date:  2010-08       Impact factor: 1.351

Review 6.  Use of rifampin in nonstaphylococcal, nonmycobacterial disease.

Authors:  A B Morris; R B Brown; M Sands
Journal:  Antimicrob Agents Chemother       Date:  1993-01       Impact factor: 5.191

Review 7.  Brucellosis in India - a review.

Authors:  Basappa G Mantur; Satish K Amarnath
Journal:  J Biosci       Date:  2008-11       Impact factor: 1.826

Review 8.  Clinical manifestations of human brucellosis: a systematic review and meta-analysis.

Authors:  Anna S Dean; Lisa Crump; Helena Greter; Jan Hattendorf; Esther Schelling; Jakob Zinsstag
Journal:  PLoS Negl Trop Dis       Date:  2012-12-06

Review 9.  Systematic review and meta-analysis of randomized clinical trials in the treatment of human brucellosis.

Authors:  Julián Solís García del Pozo; Javier Solera
Journal:  PLoS One       Date:  2012-02-29       Impact factor: 3.240

10.  Time-space clustering of human brucellosis, California, 1973-1992.

Authors:  Geoffrey T Fosgate; Tim E Carpenter; Bruno B Chomel; James T Case; Emilio E DeBess; Kevin F Reilly
Journal:  Emerg Infect Dis       Date:  2002-07       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.